Katonah, NY, United States of America

Charles A Altar

This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles A Altar. Retrieved from https://idiyas.com/inventor/charles-a-altar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Charles A. Altar

Introduction

Charles A. Altar is an accomplished inventor based in Katonah, NY (US). He has made significant contributions to the field of neurobiology, particularly in the area of pain management. His innovative approach to producing analgesia has garnered attention in both scientific and medical communities.

Latest Patents

Charles A. Altar holds a patent for a method of producing analgesia using neurotrophins. This patent, which involves infusions of brain-derived neurotrophic factor, neurotrophin-3, or neurotrophin-4, outlines a novel approach to alleviating pain in mammals. Additionally, these neurotrophins are utilized to treat various diseases or disorders mediated by serotonin. He has 1 patent to his name.

Career Highlights

Altar is currently associated with Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its innovative therapies. His work at Regeneron has allowed him to further explore the therapeutic potential of neurotrophins in pain management and other medical applications.

Collaborations

Throughout his career, Charles has collaborated with notable colleagues, including Judith Siuciak and Ronald M. Lindsay. These partnerships have contributed to the advancement of research in neurobiology and pain management.

Conclusion

Charles A. Altar's contributions to the field of neurobiology, particularly through his patent on neurotrophins for analgesia, highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the landscape of pain management and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…